With its second quarter results in the books, Raymond James analyst Michael W. Freeman has raised its price target on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP). On November 7, MDP reported its Q2, 2025 results. The company posted Adjusted EBITDA of $6.0-million on revenue of $26.3-million, a topline that was […]
“We are a tech company.” The stock has been on fire since August, and CEO Corey Giasson says innovation is much of the reason for the success of Mustgrow Biologics (Mustgrow Biologics Stock Quote, Chart, News, Analysts, Financials TSXV:MGRO). Mustgrow is a Saskatchewan-based AgTech company that uses materials from mustard plant to create organic biocontrol […]
Share
Tweet
Share
